Dividends Calendar Earnings Calendar
NBIX

NBIX | Neurocrine Biosciences Inc

Neurocrine Biosciences Inc
Category: Consumer goods
  • Industry: Drug Manufacturers - Major

Quick infos

  • Headquarters:   San Diego, California, United States

Trade prices

  • Volume:
  • Market Cap: 9.64B
  • Prev closed:
  • Open:
  • High:
  • Low:
  • 52 week low:
  • 52 week high:
  • Dividends:No Dividends

Next ER: November 1, 2021  After Market Closes



Top Stories (NBIX)

    About the Company

    Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 1, 20210.23 / 0.6095296M / 297.69M
    August 3, 20210.43 / 0.5019288.9M / 273.19MBeat!
    May 5, 20210.33 / 0.5276236.6M / 250.67M
    February 4, 20213.58 / 0.6014247.9M / 260.45M
    November 9, 2020-0.62 / -0.0194258.5M / 282.7M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 12, 2021 88.00 89.23
    89.97
    87.47
    1.06M -1.38%
    Nov 11, 2021 89.23 92.42
    92.48
    88.91
    639.58K -2.87%
    Nov 10, 2021 91.87 92.04
    93.59
    91.10
    427.98K -0.22%
    Nov 9, 2021 92.07 93.35
    93.90
    91.50
    413.36K -1.6%
    Nov 8, 2021 93.57 93.13
    93.93
    92.02
    744.94K 0.39%
    Nov 5, 2021 93.21 92.69
    95.22
    91.28
    1.03M 0.49%
    Nov 4, 2021 92.76 93.45
    93.69
    90.74
    1.07M -0.73%
    Nov 3, 2021 93.44 94.37
    96.35
    93.23
    914.09K -2.24%
    Nov 2, 2021 95.58 97.48
    99.00
    91.99
    2.80M -10.02%
    Nov 1, 2021 106.22 105.50
    108.01
    104.88
    824.82K 0.77%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1992
    • Employees:700

    News

    News for (NBIX)

    This company doesn't provide a dividend.


    Talk about Neurocrine Biosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 1, 2021 (Same day)

    l car spg mos rig pcg wmb mck clx leg nxpi ben 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 72
    HOLD 28
    SELL 0

    Their Official Profiles 

    WikipediaLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis